Once a stigmatized disease, AIDS is now a primary focus for many researchers seeking to address deadly health problems and potentially save the lives of millions of men, women and children. AIDS killed 1.5 million people worldwide last year, a staggering number that has drawn the attention of the Bill & Melinda Gates Foundation. Addressing this disease is a priority for the Gates Foundation, as is evidenced by all the work they have done to select and fund promising research. Fortunately, scientists all over the world are searching for innovative solutions to curing this disease. The Gates Foundation has found one likely contender for a vaccine that may also work as a cure in the work of a science researcher at Oregon Health and Science University.
Science Market Update
Malaria is a devastating global health problem in many parts of the world, having caused nearly 215 million infections internationally and 655,000 deaths per year. Most people know malaria is transmitted by the bite of an infective mosquito: the female Anopheles mosquito in particular. There are other less common methods of transmission as well, including blood transfusion, organ transplantation, needle sharing and when a mother gives birth to a child.
Oregon Health and Science University along with two other public Oregon schools recently opened a new life sciences building, the state’s largest academic building, on Portland’s South Waterfront. The project received $110 million in life science funding from taxpayers, $92 million in funding from Oregon Health and Science University institutional funding, $83 million from OHSU philanthropy and $10 million from the TriMet regional mass transit agency. The riverfront property for the new research building was donated by the Schnitzer family to help OHSU increase its campus presence in Portland.
The Oregon State University Superfund Research Program recently received $3 million in life science funding from the National Institutes of Health. This multi-investigator, multi-disciplinary and multi-institution program makes its goal the development of new technologies to assess polycyclic aromatic hydrocarbons (PAHs) present at many Superfund sites and the analysis of the potential risk these hydrocarbons may have for people who come in contact with them. The NIH Project Information page goes into more details on the goals of the Oregon State University Superfund Research Program:
Researchers at the University of Oregon, Eugene recently received $3.1 million in life science funding from the National Institutes of Health to fund a zebrafish model organism database. Dr. Monte Westerfield, the project leader, is a professor of biology at the University of Oregon. His research interests include understanding the mechanisms that regulate the differentiation of neurons as well as understanding the molecular genetics of ear and eye and development. The NIH Project Information page provides more details on the goals of the study receiving this latest round of life science funding:
Researchers at the University of Oregon have used the Electroencephalogram (EEG) electrode to tape the rhythm of memory as memories occur in near real time in the human brain. This research includes 25 student subjects and is led by Professor Edward Awh in the University of Oregon Department of Psychology and Institute of Neuroscience.
The National Science Foundation has just rewarded a grant of $200,000 to Professor Adam Higgins from Oregon State University for the prevention of sepsis. Adam Higgins is the Principal Investigator on the grant, and he is an assistant professor in the Oregon State University School of Chemical, Biological and Environmental Engineering.
This month the Knight Cancer Institute at Oregon Health and Science University (OHSU) received a $10 million gift from Columbia Sportswear President and Chief Executive Officer Tim Boyle to recruit and support the next generation of cancer researchers.
Researchers in the Linus Pauling Institute at Oregon State University discovered a copper compound to form the basis for a therapy for Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig’s disease.
When taking into account a new grant to Oregon Health and Science University and recent NIH and NSF research funding, Oregon Health and Science University is a great market for lab suppliers marketing life science solutions and hoping to generate laboratory sales leads. Oregon Health and Science University was recently awarded $50 thousand in research funding by the National Psoriasis Foundation.